We are live on ! Find out more
ACM

Atika Capital Management Portfolio holdings

AUM $796M
1-Year Est. Return 167.57%
This Fund
S&P 500
This Quarter Est. Return
+24.25%
1 Year Est. Return
+167.57%
3 Year Est. Return
+553.47%
5 Year Est. Return
+1,283.26%
10 Year Est. Return
+44,203.78%
AUM
$518M
AUM Growth
+$42.9M
Cap. Flow
-$57M
Cap. Flow %
-11.01%
Top 10 Hldgs %
30.31%
Holding
98
New
21
Increased
21
Reduced
22
Closed
25

Top Buys

Rank Stock Value
1
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
+$11.4M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$10.8M
3
THO icon
Thor Industries
THO
+$8.71M
4
CNC icon
Centene
CNC
+$7.27M
5
SRPT icon
Sarepta Therapeutics
SRPT
+$7.27M

Top Sells

Rank Stock Value
1
TWTR
Twitter, Inc.
TWTR
+$8.32M
2
MDCO
Medicines Co
MDCO
+$8.27M
3
DIS icon
Walt Disney
DIS
+$6.25M
4
QTWO icon
Q2 Holdings
QTWO
+$5.91M
5
ROKU icon
Roku
ROKU
+$5.36M

Sector Composition

Rank Sector Weight
1 Healthcare 35.56%
2 Technology 16.92%
3 Consumer Discretionary 12.84%
4 Communication Services 10.59%
5 Financials 4.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RARE icon
76
Ultragenyx Pharmaceutical
RARE
$2.46B
$231K 0.04%
+5,402
New +$223K
DIS icon
77
Walt Disney
DIS
$177B
– –
-48,000
Closed -$6.25M
ETSY icon
78
Etsy
ETSY
$8.15B
– –
-93,000
Closed -$5.25M
IWM icon
79
PUT
iShares Russell 2000 ETF
IWM
$82.5B
– –
-100,000
Closed -$15.1M
JWN
80
DELISTED
Nordstrom
JWN
– –
-40,000
Closed -$1.35M
MCK icon
81
CALL
McKesson
MCK
$103B
– –
-100,000
Closed -$13.7M
MDGL icon
82
CALL
Madrigal Pharmaceuticals
MDGL
$11.9B
– –
-40,000
Closed -$3.45M
NYT icon
83
New York Times
NYT
$10.6B
– –
-54,000
Closed -$1.54M
OKTA icon
84
PUT
Okta
OKTA
$25.6B
– –
-10,000
Closed -$984K
PINS icon
85
Pinterest
PINS
$13.1B
– –
-191,800
Closed -$5.07M
QQQ icon
86
PUT
Invesco QQQ Trust
QQQ
$480B
– –
-150,000
Closed -$28.3M
QTWO icon
87
Q2 Holdings
QTWO
$3.97B
– –
-74,900
Closed -$5.91M
VAC icon
88
CALL
Marriott Vacations Worldwide
VAC
$3.49B
– –
-48,000
Closed -$4.97M
VAC icon
89
Marriott Vacations Worldwide
VAC
$3.49B
– –
-2,000
Closed -$207K
VCYT icon
90
Veracyte
VCYT
$3.71B
– –
-145,000
Closed -$3.48M
MRTX
91
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
– –
-23,000
Closed -$2.22M
TWTR
92
DELISTED
Twitter, Inc.
TWTR
– –
-202,000
Closed -$8.32M
PLAN
93
DELISTED
Anaplan, Inc.
PLAN
– –
-86,000
Closed -$4.04M
PLAN
94
PUT
DELISTED
Anaplan, Inc.
PLAN
– –
-40,000
Closed -$1.88M
ARNA
95
PUT
DELISTED
Arena Pharmaceuticals Inc
ARNA
– –
-40,000
Closed -$1.83M
PTLA
96
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
– –
-94,000
Closed -$2.52M
MDCO
97
DELISTED
Medicines Co
MDCO
– –
-124,000
Closed -$8.27M
MDCO
98
PUT
DELISTED
Medicines Co
MDCO
– –
-30,000
Closed -$1.5M
1 2 3
4

Similar funds

AGA
Arkos Global Advisors Houston, Texas $797M AUM 15.28% 1-Year Est. Return
ACM
Ashe Capital Management Englewood Cliffs, New Jersey $797M AUM 4.79% 1-Year Est. Return
LSA
L & S Advisors Los Angeles, California $795M AUM 52.77% 1-Year Est. Return
GWA
Geometric Wealth Advisors Washington, District of Columbia $799M AUM 22.19% 1-Year Est. Return
HP
Hound Partners New York $799M AUM 9.54% 1-Year Est. Return
SC
Soundwatch Capital Rowayton, Connecticut $793M AUM 15.45% 1-Year Est. Return
LWM
Liberty Wealth Management Oakland, California $800M AUM 20.44% 1-Year Est. Return
NW
Naviter Wealth Little Rock, Arkansas $801M AUM 22.2% 1-Year Est. Return

Atika Capital Management's Q4 2019 Portfolio in Review

As of Q4 2019, Atika Capital Management held 98 positions worth $518M, up 9% from $475M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Atika Capital Management withdrew a net $57M in Q4 2019, closing 25 positions and reducing 22 holdings. Its most notable exit was Twitter, Inc., an estimated $8.32M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, up from 24% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Atika Capital Management opened a new position in Reata Pharmaceuticals, Inc. Class A Common Stock worth $12.8M.

  • Atika Capital Management's largest Q4 2019 buy was Reata Pharmaceuticals, Inc. Class A Common Stock: 62,500 shares worth $12.8M.
  • Atika Capital Management added most to Enphase Energy in Q4 2019, an estimated $3.43M increase.
  • Atika Capital Management's biggest Q4 2019 reduction was Roku, cutting an estimated $5.36M.
  • Atika Capital Management fully exited Twitter, Inc. in Q4 2019, selling an estimated $8.32M.
  • Atika Capital Management's ten largest holdings make up 30% of its $518M portfolio in Q4 2019.
  • Atika Capital Management opened 21 new positions and closed 25 in Q4 2019.
  • Atika Capital Management's portfolio value rose 9% quarter-over-quarter to $518M.

Based on Atika Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.